From a patients perspective, both treatments work in the background to reduce hunger and improve how your body handles food
Retatrutide is a next-generation triple agonist peptide targeting the GIP (glucose-dependent insulinotropic polypeptide) , GLP-1 (glucagon-like peptide-1) , and glucagon receptors
This particular form of hair loss is a condition called telogen effluvium - short-term hair loss thats triggered by physical or emotional stress
Insert the needle, draw your dose, then withdraw the needle without injecting air back into the vial to equalize pressure
Life 16 , 11651169 (2023)
Key outcomes: Mean weight loss: 14.9% (vs 2.4% placebo) 86.4% of participants achieved 5% loss (vs 31.5% placebo) 50.5% achieved 15% loss (vs 4.9% placebo) SELECT (Lincoff et al., NEJM 2023) added the cardiovascular signature: in 17,604 non-diabetic adults with prior CV history, semaglutide 2.4 mg reduced MACE (CV death, MI, stroke) by 20% over 3 years